Aimex Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.83 M
- Company Age 21 Year, 2 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth -99.99%
- Profit Growth -100.00%
- Ebitda -100.00%
- Net Worth -3.54%
- Total Assets -3.00%
About Aimex Remedies
Aimex Remedies Private Limited (ARPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 December 2003 and has a history of 21 years and two months. Its registered office is in Chandrapur, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.83 M, as per Ministry of Corporate Affairs (MCA) records.
Sandip Poshattiwar and Sachin Poshattiwar serve as directors at the Company.
Company Details
- Location
Chandrapur, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230MH2003PTC143557
- Company No.
143557
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 2003
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Aimex Remedies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandip Poshattiwar  | Director | 16-Dec-2003 | Current |
| Sachin Poshattiwar | Director | 16-Dec-2003 | Current |
Financial Performance of Aimex Remedies.
Aimex Remedies Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 99.99% decrease. The company also saw a substantial fall in profitability, with a 100% decrease in profit. The company's net worth dipped by a decrease of 3.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aimex Remedies?
In 2018, Aimex Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shri Narakesari Prakashan LimitedSandip Poshattiwar is a mutual person
Sarathya Engineering Private LimitedSandip Poshattiwar is a mutual person
- Posh Logistics Private Limited
Sandip Poshattiwar and Sachin Poshattiwar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aimex Remedies?
Unlock and access historical data on people associated with Aimex Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aimex Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aimex Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.